NYSE: ACT       Advisorshares Vice ETF
Last Price Today's Change   Day's Range   Trading Volume
22.62   -0.319 (1.39%)  22.62 - 22.85  561


Avg Volume (4 weeks):2,889
4 Weeks Range:20.75 - 23.29
4 Weeks Price Volatility (%):
52 Weeks Range:16.16 - 25.85
52 Weeks Price Volatility (%):
Average Price Target: 340.00
Price Target Upside/Downside: +317.38


No recent Headlines for this stock.

Business Background

Actavis plc is a global, integrated specialty pharmaceutical company. The Company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company produces and markets generic, branded generic, branded and over-the-counter (OTC) pharmaceutical products covering all therapeutic classes. The Company's product formulations include modified release, solid oral dosage, semi-solids, suspensions, transdermals, suppositories, creams, ointments, liquids and injectables. In October 2013, Actavis Inc acquired Warner Chilcott PLC and in connection with the acquisition, Actavis Inc and Warner Chilcott PLC have been combined under a new company, Actavis plc.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2142  3519  377  2913 

Top 10 Active Counters
 JCP 0.1820.00 
 AVP 5.60-0.05 
 GE 6.517-0.263 
 PHIO 4.06+1.82 
 PRTY 1.422+0.402 
 AABA 19.630.00 
 ADAP 9.95+5.09 
 TGE 22.39+0.81 
 SQQQ 9.75-0.08 
 F 5.685-0.165 
Partners & Brokers